Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

DG 381B

Copy Product Info
😃Good
Catalog No. TN8310Cas No. 564-16-9
Alias STX122, STX 122, DG381B, 11-Deoxyglycyrrhetinic acid

DG 381B (11-Deoxyglycyrrhetinic acid) has anti-inflammatory and potential anticancer activities, significantly inhibiting gastric cancer cell viability in a dose- and time-dependent manner. It induces apoptosis and G2 cell cycle arrest by upregulating p21 and downregulating cdc2 and cyclin B1 in gastric cancer cells.

DG 381B

DG 381B

Copy Product Info
😃Good
Purity: 95.14%
Catalog No. TN8310Alias STX122, STX 122, DG381B, 11-Deoxyglycyrrhetinic acidCas No. 564-16-9
DG 381B (11-Deoxyglycyrrhetinic acid) has anti-inflammatory and potential anticancer activities, significantly inhibiting gastric cancer cell viability in a dose- and time-dependent manner. It induces apoptosis and G2 cell cycle arrest by upregulating p21 and downregulating cdc2 and cyclin B1 in gastric cancer cells.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$218InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95.14%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
DG 381B (11-Deoxyglycyrrhetinic acid) has anti-inflammatory and potential anticancer activities, significantly inhibiting gastric cancer cell viability in a dose- and time-dependent manner. It induces apoptosis and G2 cell cycle arrest by upregulating p21 and downregulating cdc2 and cyclin B1 in gastric cancer cells.
In vitro
DG 381B induced apoptosis and G2 phase cell cycle arrest by up-regulating p21 and down-regulating cdc2 and cyclin B1, and significantly inhibited the viability of gastric cancer cells in a dose - and time-dependent manner. [1]
In vivo
DG 381B can effectively inhibit the tumor formation of gastric cancer cells in nude mice. [1]
SynonymsSTX122, STX 122, DG381B, 11-Deoxyglycyrrhetinic acid
Chemical Properties
Molecular Weight456.7
FormulaC30H48O3
Cas No.564-16-9
SmilesC[C@]12[C@@]([C@]3(C)[C@@](CC1)(C(C)(C)[C@@H](O)CC3)[H])(CC=C4[C@@]2(C)CC[C@]5(C)[C@]4(C[C@](C(O)=O)(C)CC5)[H])[H]
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy DG 381B | purchase DG 381B | DG 381B cost | order DG 381B | DG 381B chemical structure | DG 381B in vivo | DG 381B in vitro | DG 381B formula | DG 381B molecular weight